Magnesium Alloy Implant Catalyst Hydrogen Conversion
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Magnesium-based biodegradable implants face issues with hydrogen gas formation during degradation, which can harm tissues and cause gas pockets, as existing methods only slow down the degradation rate without reducing the total hydrogen release.
Innovation Solution
Incorporating catalysts into magnesium or magnesium alloys to catalytically convert hydrogen gas to water or other compounds, either by dispersion within the matrix or surface treatment, utilizing platinum group metals, metal oxides, or carbides to reduce hydrogen evolution.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Strength
If magnesium-based implants are used for biodegradable applications, then mechanical stability and biocompatibility are improved, but hydrogen gas formation increases causing tissue harm and gas pockets
Solution Approach 1:
The patent applies catalysts (such as platinum group metals, metal oxides, or carbides) to the magnesium-based implant surface to catalytically convert the harmful hydrogen gas produced during degradation into water or other benign compounds. This transforms the harmful hydrogen evolution process into a beneficial catalytic conversion, eliminating gas pockets and tissue damage while preserving the biodegradable advantage of magnesium implants.
Solution Approach 2:
The patent creates a composite material system by combining magnesium-based alloy with catalytic materials (metal particles, oxides, or carbides). This composite structure integrates the mechanical stability of magnesium with the hydrogen-converting properties of the catalyst, achieving both structural integrity and reduced hydrogen gas formation during implant degradation.
2Productivity
If degradation rate is slowed down by alloying or surface modification, then hydrogen release rate is reduced, but total hydrogen released remains unchanged
Solution Approach 1:
Instead of merely slowing down the degradation rate through conventional alloying or surface modification, the patent introduces catalysts that actively convert the hydrogen gas produced during degradation into water. This catalytic conversion addresses the total hydrogen release issue directly, transforming harmful hydrogen into benign products while allowing the implant to maintain an appropriate degradation rate for its function.
3Reliability
If conventional corrosion resistance methods are applied to magnesium implants, then degradation rate is reduced, but mechanical properties and biocompatibility are compromised
Solution Approach 1:
The patent applies catalytic materials locally on the implant surface rather than through bulk alloying or extensive surface modification. This localized approach allows the magnesium bulk to maintain its mechanical properties and biocompatibility, while the surface catalysts specifically address the hydrogen gas formation issue during degradation, achieving corrosion resistance without sacrificing mechanical integrity.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The solution effectively reduces hydrogen gas emission during implant degradation, maintaining mechanical and corrosion properties while allowing for controlled degradation rates, suitable for various medical applications including coronary stents and vascular closure devices.
Implementation Method 1
Incorporating catalysts into magnesium or magnesium alloys to catalytically convert hydrogen gas to water or other compounds
Data Source
Figure 1
Figure 2
AI summary
A composite material for a medical implant includes a matrix of magnesium or magnesium alloy, and a catalyst which is dispersed within the matrix. The catalyst has the capacity to reduce an amount of hydrogen gas released from the matrix when the matrix is being degraded inside the patient.